Clinical Trials
29 trialsOncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
Fujian Cancer Hospital
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure
Henan Cancer Hospital
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
KK Women's and Children's Hospital
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
Dr. Soetomo General Hospital
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
SOROCOV
Butantan Institute
T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
Sheba Medical Center
Modelle 001, TS-inhibition in Colorectal Liver Metastases Comparing Arfolitixorin and Calciumfolinate
Vastra Gotaland Region
CH1701
Vietlife Healthcare Corporation
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer
Henan Cancer Hospital
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer
Henan Cancer Hospital
Stem Cell Therapy Combined With NeuroRegen Scaffoldâ„¢ in Patients With Erectile Dysfunction After Rectal Cancer Surgery
Chinese Academy of Sciences
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Tel-Aviv Sourasky Medical Center
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
Study of BCMA CAR-T in Multiple Myeloma
Henan Cancer Hospital
A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)
Vastra Gotaland Region
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
Henan Cancer Hospital
Lonquek for Autologous Stem Cell Mobilization
Sheba Medical Center
B-DUOL
Basque Health Service
Limiting Chemotherapy Side Effects by Using Moxa
East and North Hertfordshire NHS Trust
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Medical Research Council
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Burnasyan Federal Medical Biophysical Center
5-ALA
Tel-Aviv Sourasky Medical Center
BNCT and IG-IMRT for Recurrent Head and Neck Cancer
Taipei Veterans General Hospital, Taiwan
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
National Cancer Center, Korea
OSCAT
Tata Memorial Hospital
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Pain Relief - Tramadol Versus Ibuprofen
Royal Liverpool University Hospital